Yahoo Lifestyle Dane DeHaan Joins ‘Neuromancer’ Apple TV+ Series
Dane DeHaan (American Primeval, Oppenheimer) has been tapped for a major recurring role opposite leads Callum Turner and Briana Middleton in Neuromancer, Apple TV+‘s 10-episode drama series based on the award-winning novel of the same name by William Gibson.
Created for television by Graham Roland and JD Dillard, Neuromancer follows a damaged, top-rung super-hacker named Case (Turner) who is thrust into a web of digital espionage and high-stakes crime with his partner Molly (Middleton), a razor-girl assassin with mirrored eyes, aiming to pull a heist on a corporate dynasty with untold secrets.
More from Deadline
Apple Greenlights New Sci-Fi Drama Series ‘Neuromancer’ Based On William Gibson Novel
All The Songs In 'Severance' Season 2: From The Who To Ella Fitzgerald
DeHaan will play Peter Riviera.
In addition to Turner and Middleton, DeHaan joins previously announced Joseph Lee, Mark Strong, Cleménce Poésy and Peter Sarsgaard.
A co-production between Skydance Television, Anonymous Content and Apple Studios, Neuromancer is also produced by Drake’s DreamCrew Entertainment. Roland will serve as showrunner and Dillard is set to direct the pilot episode.
Neuromancer is executive produced by Roland and Dillard alongside David Ellison, Dana Goldberg and Matt Thunell for Skydance Television; Anonymous Content; Drake, Adel ‘Future’ Nur and Jason Shrier for DreamCrew; Zack Hayden; and Gibson.
DeHaan was recently seen in Peter Berg’s Netflix limited series American Primeval, Christopher Nolan’s Oppenheimer and Craig Gillespie’s Dumb Money, as well as Max’s The Staircase opposite Colin Firth and Toni Collette. He recently wrapped filming indie crime thriller Wardriver, opposite Sasha Calle.
He is represented by Gersh, MGMT Entertainment, and Sloane, Offer, Weber & Dern.
Best of Deadline
Everything We Know About Paramount’s ‘Regretting You’ Adaptation So Far
List Of Hollywood & Media Layoffs From Paramount To Warner Bros Discovery To CNN & More
Sign up for Deadline's Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.
